1 / 57

ASCITES & PERITONITIS

ASCITES & PERITONITIS. Diagnosis of Ascites. Physical exam: Shifting dullness Fluid wave Organ ballotment For cirrhosis related ascites: stigmata of cirrhosis Jaundice Spider angioma Muscle wasting Abdominal wall collaterals. Physical Exam for Ascites.

gyan
Télécharger la présentation

ASCITES & PERITONITIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ASCITES& PERITONITIS

  2. Diagnosis of Ascites • Physical exam: • Shifting dullness • Fluid wave • Organ ballotment • For cirrhosis related ascites: stigmata of cirrhosis • Jaundice • Spider angioma • Muscle wasting • Abdominal wall collaterals

  3. Physical Exam for Ascites • Sensitivity and specificity related to volume and body habitus • 50-90% sensitive • 30-80% specific • Absence of any flank dullness is best indicator of no/minimal ascites (under 1500 cc)

  4. Causes of Ascites • Cirrhosis/Acute hepatic injury (~80%) ( 5% have multifactorial cause) • Malignancy ( ~ 10%) • Right sided heart failure (3%) • Renal disease (1%) • Pancreatic (1%) • TB (2%) • Other ( SLE, myxedema, surgical complication: chylous: 2%) • HIV ( 75% cirrhosis and 25 % HIV related: TB, fungal, lymphoma) History should make diagnosis

  5. Causes • Cirrhosis causes 80-85% of ascites • Underfill vs Overlow theories • Recent Peripheral Arterial Vasodilation theory: incorporates both • Fundamental abnormality is Portal HTN • PHT--> nitric oxide--> vasodilation--> renal Na retention--> overfill of intravasc vol--> ascites formation--> neurohumoral activation • figure 78.1

  6. Pathogenesis

  7. Physical Exam Related to Pathophysiology of Hepatic Ascites • Portal hypertension • Ascites • Varices/ collaterals • Palmer erythema and gonadal atrophy • estrogen metabolic impairment • Arterial vascular “under filling” • Flat neck veins • System relative hypotension • Tachycardia

  8. Evaluation • Radiology: US supplanted by CT • Signs of cirrhosis • Malignancy • Portal vein thrombosis • Hepatic vein thrombosis Caveat is risk of IV contrast with the common underlying renal insufficiency/volume depletion of associated conditions

  9. Paracentesis • Ascites fluid analysis in all patients with • New onset ascites • Abdominal pain and known ascites • Fever and ascites Clinical deterioration of any kind

  10. Pathogenesis: Non-Liver disease • Depends on site of abnormality • Malignancies • peritoneal carcinomatosis- exudation of proteinaceous fluid from tumor cells lining peri • Massive liver mets- portal HTN • Hepatocellular CA- underlying cirrhosis, PVT • Lymphoma- chylous ascites, obstruction of LN • Cardiac- hear failure, PHT

  11. Clinical Features • Pts with stable cirrhosis and “sudden”ascites, suspect hepatocellular CA • Should suspect malignant ascites in pts with malignancy however need to rule out cirrhosis • Breast, lung, colon and pancreatic are often complicated by ascites • Malignant ascites is usually painful

  12. Diagnosis: Paracentesis • Complications of Paracentesis: • Rare and related to inexperience • Perforation • Past surgery and adhesions to peritoneum • Absence of ascites • Bleeding • Coagulapathy (clotting factors and thrombocytopenia) • Abdominal wall collaterals • Studies have excluded those with INR over 1.6 /PT over 21 seconds and Plt under 50,000 or clinically evident DIC • Leak • Large bore catheter • Tense ascites

  13. Paracentesis: technique • Avoid surgical scar- risk of adhesions • Supine or lateral decubitus • Tap out area of shifting dullness • Head of bed slightly elevated • Avoid collaterals and inferior hypogastric artery • Left or Right lateral versus midline • Main issue is to examine for contraindications to use of site and optimal area of shifting dullness • Scant ascites, scars and or obesity w/o shifting dullness • Prone near midline: “puddle” • US guided if not emergently needed in this setting

  14. Paracentesis: technique • Needle • Bruce Runyon: Up to Date and Slesinger and Fortran • 1.5” 22 gauge diagnostic and 16 gauge for large volume • 3.5” spinal for obese abdominal wall • Steel needle or blunt tipped cannula with sharp stylet that can be removed • Goldkind: Boston University/Boston City Hospital • Angiocath : do not reinsert metal stylet after insertion in to abdominal wall to prevent sheering off of plastic • Angiocath may be less likely to perforate bowel or nick vessel after metal stylet removed • Kinking is an issue

  15. Culture • SBP most common bacterial infection • usually monomicrobial • low bacteria count • Conventional plating not sensitive (50%) • Bedside inoculation of blood culture bottles 80% sensitive

  16. Appropriate Tests • Cell count single most helpful test • EDTA purple top tube • WBC in cirrhotics usually < 500cells/m3 • PMN > 250cells/m3 ABNORMAL • SBP most common cause of increased WBC • Traumatic tap accounts for most bloody ascites (subtract 1 PMN for each 250 RBCs)

  17. Diagnosing TB • AFB from ascites almost always negative • centrifuged pellet only 50% sensitive • Best method- peritoneal biopsy and culture combined for close to 100% sensitivity

  18. Cytology • Should be expected in malignancies with cells lining the peritoneum • Essentially 100% of pts with peritoneal carcinomatosis have positive cytology • Other malignancies (mets, hepatocellular CA) may cause ascites but may have negative cytology

  19. Serum-Ascites Albumin Gradient • Before the 1980s we used transudate vs. exudate, never fully validated • SAAG has been shown superior to exudate-transudate categories and total protein values in several studies • SAAG= serum albumin - ascites albumin (same day specimens) • Correlates with portal pressure Discard Transudate and Exudate terminology

  20. Serum-Ascites Albumin Gradient • SAAG > 1.1 g/dL (11 g/L), • pt has portal HTN (97% accuracy) • SAAG < 1.1 g/dL, no portal HTN • Does not give pathogenesis or dx cirrhosis • Not affected by: • infection, diuresis, etiology of liver disease • Not a test for peritonitis • cell count and culture used for this question

  21. Cirrhosis Alcoholic Hepatitis Cardiac ascites “Mixed” ascites Hepatic failure Budd-Chiari syndrome Portal vein thrombosis Veno-occlusive dis. Myxedema Fatty liver of pregnancy SAAG: high gradient >1.1g/dL

  22. Peritoneal Carcinomatosis Tuberculous peritonitis Pancreatic ascites Bowel obstruction or infarction Biliary ascites Nephrotic Syndrome Post-op lymphatic leak Serositis in CTD SAAG: low gradient < 1.1g/dL

  23. Complications of Ascites • Infection • SBP • Tense Ascites • Respiratory compromise ( restriction) • Pain • Pleural Effusions (hepatic hydrothorax) • Abdominal Wall Hernias

  24. Spontaneous bacterial peritonitis • Correia and Conn coined term in 1975 • Goal to distinguish SBP from surgical peritonitis • Diagnosis • positive ascitic fluid culture • elevated ascitic PMN count > 250cells/mm3 and • no intra-abdominal surgically treatable source

  25. Spontaneous bacterial peritonitis • Spontaneous bacterial peritonitis (variants) • Monomicrobial non-neutracytic: • (culture + without 250 polys) • Culture negative Neutrocytic • high poly count but culture negative: simply presumed false neg culture • SBP and variants • only occur in severe liver disease • In the presence of pre-existing ascites • Almost always in patients with elevated bili and INR

  26. Begin here to finish presentation

  27. SBP: Pathogenesis • MNB: • more common than SBP • probably early stage of SBP • good opsonic activity results in sterile ascites • poor opsonic activity results in SBP • CNNA: • probably poor culture technique • resolving SBP after killing of bacteria but before normalization of PMN count

  28. SBP: presentation

  29. SBP: Prevalence • Overall 10% of pts. with ascites are infected on admission • 27% of cirrhotic ascites are infected • Secondary bacterial peritonitis occurs in <2% of pts.

  30. SBP: organisms • E. coli most common 37% • Klebsiella 17% • Pneumococcus 12% • Strep. viridans 9% • Miscellaneous • gram positive 14% • gram negative 10%

  31. SBP: Diagnosis • High index of suspicion: • Ascitic fluid PMN>250 • Signs and symptoms of infection • Rule out secondary peritonitis- imaging, surgical consult • Repeat tap after 48 hours of treatment • antibiotics can’t control secondary peritonitis but rapidly cure SBP

  32. SBP: Treatment • Empiric antibiotics for all suspected SBP • 5 days of IV antibiotics • cefotaxime 2 gm q8 better than amp and tobra • cefotaxime covered 98% of the flora • no renal toxicity • sterile culture after 1 dose in 86% of pts • change spectrum according to sensitivities • repeat tap in 48 hours to assess for change in PMN count (decline often >80%)

  33. SBP: Prognosis • Old studies 48-95% of pts died despite tx • Now <5% die of infection if timely and appropriate antibiotics are used • earlier detection, treatment • avoidance of nephrotoxic agents • Maximize survival: • tap all pts admitted to hospital • repeat if deterioration, change in sx • tap all outpatients with NEW ascites

  34. SBP: Prevention • Risk factors • previous SBP • low ascitic protein • variceal hemorrhage • Norfloxin 400 mg QD prevents SBP in low protein and previous SBP and 400mg BID for pts with variceal hemorrhage • Oral antibiotics do not prolong survival

  35. Treatment: depends on etiology • Low SAAG: • Peritoneal Carcinomatosis- most common • outpt therapeutic paracentesis • Tuberculous ascites • cured by anti-TB therapy • Pancreatic ascites • may resolve spontaneously

  36. Treatment: depends on etiology • High SAAG: • hospitalization (large volume) • diet education (low sodium) • urine sodium excretion • fluid restriction (hyponatremia) • DIURETICS • no bed rest, sodium bicarb, foleys

  37. Treatment • Hospitalization for diagnosis, large volume paracentesis • Diet education with salt restriction key to management (2gm Na/day) • Check urinary Na excretion to ensure compliance • Fluid restriction not needed unless Na < 120 or pt symptomatic

  38. Treatment • Diuretics: • Spironolactone • is mainstay of tx, better than furosemide • long half life=slow onset (2 weeks to full effect), gynecomastia, hyperkalemia • Furosemide • faster onset, hypokalemia • Amiloride • more rapid onset, more expensive • less gynecomastia

  39. Treatment • Combination diuretics most effective • Spironolactone 100mg • Furosemide 40mg • Single day dosing • Double dose when ineffective • Start simultaneously • IV not needed

  40. Treatment • No limit to weight loss in pts with massive edema • Then 0.5 Kg/day • Stop diuretics for • encephalopathy • creatinine > 2 mg/dL • sodium < 120 mmol/L

  41. Treatment: outpt management • Re-evaluate in 1-2 weeks • Goal of diuretics is weight loss (negative sodium balance) • Check urine sodium • if excretion of Na> than 88mmol/day and pt is on 88mmol Na diet, they should lose weight

  42. Refractory Ascites • Defined as fluid overload unresposive to salt restriction and high-dose diuretics • < 10% of pts with cirrhotic ascites are refractory • Viable options include peritoneovenous shunt, LVP and transplant

  43. Refractory Ascites • Peritoneovenous shunts: • complications include shunt failure, fatal complications of insertion • no survival advantage in RCT • relegation to 3rd line therapy of cirrhotic ascites

More Related